 Transaction significantly scales air purification product portfolio and customer base Developed for NASA as a patented pathogen killing technology; patents were originally obtained by KES Expands access to food distribution, grocery chains, and fast-growing cannabis market Proprietary photocatalytic oxidation process thoroughly destroys viruses including COVID-19, bacteria, spores, and fungi Accelerates the strategy to grow revenues through complimentary and synergistic acquisitions KES is expected to contribute significantly to revenues in 2022 and be immediately accretive to Applied UVs earnings per share Applied UV to host investor call at 9:00 am EDT on September 29, 2021 MOUNT VERNON, NY ACCESSWIRE September 29, 2021 Applied UV, Inc. NASDAQ:AUVI Applied UV or the Company, an infection control technology company that applies the power of narrow-range ultraviolet light UVC for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced it has closed on the acquisition by its wholly-owned subsidiary, SteriLumen, Inc. SteriLumen, of substantially all of the assets of privately-held KES Science Technology, Inc. KES and JJS Technologies, LLC JJS, each of Kennesaw, Georgia, including all of the rights to manufacture and sell all of its patented, air disinfection and purification technologies, for 4.3 million in cash and 300,000 common shares of Applied UV stock. Neither SteriLumen nor Applied UV will assume any long-term debt or non-operating liabilities of KES. 